VICENTINI, Caterina
 Distribuzione geografica
Continente #
NA - Nord America 1.257
EU - Europa 1.224
AS - Asia 510
OC - Oceania 5
SA - Sud America 3
AF - Africa 2
Totale 3.001
Nazione #
US - Stati Uniti d'America 1.251
CN - Cina 460
GB - Regno Unito 454
IT - Italia 207
SE - Svezia 131
IE - Irlanda 128
FR - Francia 99
DE - Germania 95
FI - Finlandia 51
UA - Ucraina 21
VN - Vietnam 19
BE - Belgio 14
KR - Corea 10
RU - Federazione Russa 9
AT - Austria 8
AU - Australia 5
CA - Canada 5
IR - Iran 5
IN - India 4
TR - Turchia 3
CL - Cile 2
MA - Marocco 2
NL - Olanda 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BR - Brasile 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ES - Italia 1
ID - Indonesia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MY - Malesia 1
NO - Norvegia 1
SA - Arabia Saudita 1
SG - Singapore 1
Totale 3.001
Città #
Southend 440
Chandler 319
Dublin 119
Beijing 112
Woodbridge 112
Verona 109
Ann Arbor 89
Jacksonville 78
Ashburn 74
New York 55
Houston 46
Shenyang 46
Lawrence 40
Princeton 40
Jinan 38
Wilmington 34
Dearborn 32
Hebei 24
Nanjing 23
Redmond 23
Changsha 19
Nanchang 18
Ningbo 18
Zhengzhou 18
Tianjin 17
Helsinki 16
Brussels 14
Hangzhou 13
Sindelfingen 13
Guangzhou 12
Haikou 12
Taiyuan 11
Seoul 10
Bologna 9
Jiaxing 9
Vienna 8
Dong Ket 7
Milan 7
Norwalk 7
Taizhou 7
Redwood City 6
Seattle 6
Washington 6
Fuzhou 5
Chicago 4
Lanzhou 4
Trevenzuolo 4
Andover 3
Chions 3
Lancaster 3
Melbourne 3
Menlo Park 3
Quarto D'altino 3
Rome 3
San Francisco 3
Bottrop 2
Castelnuovo 2
Cerea 2
Des Moines 2
Essen 2
Falls Church 2
Gainesville 2
Lappeenranta 2
Los Angeles 2
Modugno 2
Padova 2
Qingdao 2
Roverbella 2
Sacramento 2
Sossano 2
Tashkent 2
Toronto 2
Trieste 2
Winnipeg 2
Yicheng 2
Zanjan 2
Amsterdam 1
Augusta 1
Azzano Decimo 1
Baku 1
Bangalore 1
Bishkek 1
Boardman 1
Buffalo 1
Cambridge 1
Canberra 1
Charlotte 1
Cincinnati 1
Colombo 1
Costa Mesa 1
Crotone 1
Dongguan 1
Düsseldorf 1
Easton 1
Fairfield 1
Fiorano Modenese 1
Frankfurt am Main 1
Grafing 1
Gunzenhausen 1
Hefei 1
Totale 2.223
Nome #
Whole-genome landscape of pancreatic neuroendocrine tumours 155
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 145
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 116
Reporting tumor molecular heterogeneity in histopathological diagnosis 116
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 109
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression 102
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 100
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives 99
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 91
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 90
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 89
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 87
Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract. 81
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 80
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 78
Fhit down-regulation is an early event in pancreatic carcinogenesis 77
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 76
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 73
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 71
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 71
A differentially expressed set of micrornas in cerebro-spinal fluid (CSF) can diagnose CNS malignancies 69
MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer 68
Exosomal miRNA signatures of pancreatic lesions 65
MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7 64
Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models 64
Comparative Lesions Analysis Through a Targeted Sequencing Approach 63
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 62
COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence 61
Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex 57
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 57
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers 56
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 52
miR-15b/16-2 deletion promotes B-cell malignancies 48
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 48
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells 48
Current role of non-coding RNAs in the clinical setting 44
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 41
MCL1 as putative target in pancreatoblastoma 39
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 36
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 33
Loss of FGFR4 promotes the malignant phenotype of PDAC 31
Lamc2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth 31
Long-term organoid culture of a small intestinal neuroendocrine tumor 23
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage 20
Totale 3.086
Categoria #
all - tutte 9.902
article - articoli 9.211
book - libri 0
conference - conferenze 691
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.804


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201936 0 0 0 0 0 0 0 0 0 0 26 10
2019/2020392 36 8 13 7 21 20 71 39 29 44 61 43
2020/2021337 63 65 20 47 35 26 6 2 8 11 32 22
2021/2022424 31 136 8 38 10 7 5 28 28 7 36 90
2022/2023849 44 117 70 138 83 196 15 45 101 11 10 19
2023/2024338 18 25 39 29 57 88 19 31 5 27 0 0
Totale 3.086